Capitainer®
Sampling You Can Trust
Easy to use
High success rate for first time users. Integrated successful sample indicator.
Accurate
Quantitative sampling with the accuracy & precision of traditional pipetting.
Sample protection
The sample is protected within the device, reducing the risk of contamination.
Sampling solutions for quantitative microsample collection.
We have designed our devices to eliminate the risk of over- or under-fill and integrated an instant successful sampling indication. The device is slim and can be shipped back to the laboratory by regular mail.
Capitainer® Collection Devices
Instructions For Use
Using Capitainer® Is Simple
Capitainer®B device is intended to be used for self sampling. Where required, it can also be used for assisted sampling.
View our video to see for yourself how easy and convenient sampling is with the Capitainer®B or visit our Use page via the button below.
COVID-19
COVID-19 Antibody Testing
We believe Home Sampling has a key role to play in helping health authorities, healthcare providers and researchers to perform serological tests for efficient studies and diagnostics. Capitainer has been used by many customers with different analysis platforms. Click here to learn more on how you can use the Capitainer®B and home-sampling with our summary of others work.
Microfluidsystem Based Technology
qDBS Technology - Accuracy and precision in sampling for everyone
Anyone can collect high quality blood samples themselves at a location that is convenient to them. The samples are then sent to the laboratory for analysis through the regular mail. This is enabled by Capitainer´s qDBS technology that automatically meters and stores an exact blood volume in a protected pre-cut dried blood spot (DBS) disc.
Keep Updated
Our Latest News
Our Mission
We are improving healthcare outcomes for all by providing universally applicable precision sampling technologies.Â
Dried Blood Spot Testing – Part 1
Stratech Scientific appointed as distributor for UK and Ireland
Dried Blood Spot Microsampling in Screening and Monitoring of PKU
Capitainer raises additional SEK34 million to meet the increasing demand for home-sampling solutions